SEC Form D private-offering filing

Electra Therapeutics, Inc.

Name: Electra Therapeutics, Inc. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2025-10-30

A new SEC Form D private-offering notice from South San Francisco, CA, a $184,133,425 filer-stated offering target in Biotech. The source filing is one click away.

Electra Therapeutics, Inc. site↗ Verified via SEC Form D

Develops SIRP directed antibody therapies targeting immunological diseases and cancer, lead candidate ELA026 in clinical development for sHLH.

Filed 2025-10-30Filed to raise $184,133,425First money in 2025-10-15Raised so far $134,188,389HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) LateCall status Call-ready

Source linked the Form D on EDGAR↗Website verified electra-therapeutics.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.